Immunotherapy for nasal allergy

Research output: Contribution to journalArticle

Abstract

Controlled studies establish the effectiveness of immunotherapy for allergic rhinitis related to grasses, ragweed, mountain cedar, and birch pollens. Clinical improvement appears to be specific, to require adequate dosage, and to relapse once booster injections are discontinued. Specific immunologic responses increase blocking IgG antibodies in serum and secretions, blunt IgE responses, and reduce lymphocyte reactions. Immediate mediator release is reduced both in basophils challenged in vitro and in nasal secretions after local challenge in vivo. Effects on late-phase inflammatory reactions are still under investigation. Standardization of allergenic extracts by immunologic methods should make useful therapeutic responses more frequent.

Original languageEnglish (US)
Pages (from-to)992-996
Number of pages5
JournalThe Journal of Allergy and Clinical Immunology
Volume81
Issue number5 PART 2
DOIs
StatePublished - 1988

Fingerprint

Ambrosia
Betula
Blocking Antibodies
Basophils
Pollen
Poaceae
Nose
Immunotherapy
Immunoglobulin E
Hypersensitivity
Immunoglobulin G
Lymphocytes
Recurrence
Injections
Serum
Therapeutics
Allergic Rhinitis
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Immunotherapy for nasal allergy. / Norman, Philip S.

In: The Journal of Allergy and Clinical Immunology, Vol. 81, No. 5 PART 2, 1988, p. 992-996.

Research output: Contribution to journalArticle

@article{ac336b78b8094b76b3712546cba624e8,
title = "Immunotherapy for nasal allergy",
abstract = "Controlled studies establish the effectiveness of immunotherapy for allergic rhinitis related to grasses, ragweed, mountain cedar, and birch pollens. Clinical improvement appears to be specific, to require adequate dosage, and to relapse once booster injections are discontinued. Specific immunologic responses increase blocking IgG antibodies in serum and secretions, blunt IgE responses, and reduce lymphocyte reactions. Immediate mediator release is reduced both in basophils challenged in vitro and in nasal secretions after local challenge in vivo. Effects on late-phase inflammatory reactions are still under investigation. Standardization of allergenic extracts by immunologic methods should make useful therapeutic responses more frequent.",
author = "Norman, {Philip S.}",
year = "1988",
doi = "10.1016/0091-6749(88)90167-4",
language = "English (US)",
volume = "81",
pages = "992--996",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "5 PART 2",

}

TY - JOUR

T1 - Immunotherapy for nasal allergy

AU - Norman, Philip S.

PY - 1988

Y1 - 1988

N2 - Controlled studies establish the effectiveness of immunotherapy for allergic rhinitis related to grasses, ragweed, mountain cedar, and birch pollens. Clinical improvement appears to be specific, to require adequate dosage, and to relapse once booster injections are discontinued. Specific immunologic responses increase blocking IgG antibodies in serum and secretions, blunt IgE responses, and reduce lymphocyte reactions. Immediate mediator release is reduced both in basophils challenged in vitro and in nasal secretions after local challenge in vivo. Effects on late-phase inflammatory reactions are still under investigation. Standardization of allergenic extracts by immunologic methods should make useful therapeutic responses more frequent.

AB - Controlled studies establish the effectiveness of immunotherapy for allergic rhinitis related to grasses, ragweed, mountain cedar, and birch pollens. Clinical improvement appears to be specific, to require adequate dosage, and to relapse once booster injections are discontinued. Specific immunologic responses increase blocking IgG antibodies in serum and secretions, blunt IgE responses, and reduce lymphocyte reactions. Immediate mediator release is reduced both in basophils challenged in vitro and in nasal secretions after local challenge in vivo. Effects on late-phase inflammatory reactions are still under investigation. Standardization of allergenic extracts by immunologic methods should make useful therapeutic responses more frequent.

UR - http://www.scopus.com/inward/record.url?scp=0023950704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023950704&partnerID=8YFLogxK

U2 - 10.1016/0091-6749(88)90167-4

DO - 10.1016/0091-6749(88)90167-4

M3 - Article

C2 - 3372917

AN - SCOPUS:0023950704

VL - 81

SP - 992

EP - 996

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 5 PART 2

ER -